BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Clinical & Diagnostic

Genea Biomedx Joins Basecare Medical to Drive Global Expansion of Assisted Reproductive Technology

Genea Biomedx, which was once part of Genea Fertility, joined the Basecare Medical group in 2023 with the aim of distributing Basecare's assisted reproduct...

September 13, 2024 | News

Nona Biosciences and Umoja Biopharma Partner to Advance Next-Generation CAR-T Cell Therapies

Nona Biosciences, a global biotechnology company providing a total solution from "Idea to IND" (I to ITM), announced that it has entered into a multi...

September 13, 2024 | News

Senhwa Biosciences' Silmitasertib Receives Rare Pediatric Disease Designation from US FDA for Neuroblastoma

Senhwa Biosciences, Inc. (TPEx: 6492), a new drug development company focusing on first-in-class therapeutics for oncology, rare diseases, and infectious d...

September 13, 2024 | News

Abacus Medicine Partners with Mirum Pharmaceuticals to Commercialize LIVMARLI® in the Nordic Region

Abacus Medicine Pharma Services (‘Abacus’) announces the signing of a partnership agreement with Mirum Pharmaceuticals, Inc. (‘Mirum...

September 11, 2024 | News

A. Menarini Diagnostics and Nucleix Partner for Non-Invasive Bladder Cancer Test in Europe

Under the commercial agreement, A. Menarini Diagnostics will assume exclusive marketing of the non-invasive Bladder EpiCheck® test in Europe&...

September 10, 2024 | News

Lunit Integrates AI Biomarker into Roche's navify® Platform, Boosting Precision in Cancer Biomarker Testing

Lunit's AI-powered biomarker, Lunit SCOPE PD-L1 TPS, integrates into Roche's navify® Digital Pathology platform to enhance precision medicine an...

September 10, 2024 | News

Seegene Launches Advanced Novaplex™ Assay to Combat High-Mortality Mpox Clade I

Introduces Novaplex™ MPXV/OPXV plus Assay (RUO) that is designed to detect Clade I, which has higher transmission and mortality rates than Cla...

September 10, 2024 | News

Merck Launches Global Phase III Trial of Oral Cladribine for Generalized Myasthenia Gravis Treatment

MyClad is a global Phase III study evaluating the efficacy and safety of cladribine capsules for the treatment of generalized Myasthenia Gravis (gMG) Cl...

September 06, 2024 | News

GC Biopharma and Hanmi Pharmaceutical Receive FDA Clearance for Phase 1/2 Trial of First Once-Monthly Subcutaneous Treatment for Fabry Disease

Co-development of innovative new drug for the treatment of Fabry disease as "the world's first once-monthly subcutaneous treatment" Improves efficacy co...

September 04, 2024 | News

Albatroz Therapeutics Joins Johnson & Johnson Innovation – JLABS Singapore to Accelerate Cancer Therapy Development

Albatroz Therapeutics, a biotechnology company developing novel therapies against cancer and other indications, today announced its membership of Johnson &...

September 04, 2024 | News

Sanyou Biopharmaceuticals Introduces Comprehensive Monkeypox Product Line Featuring Antigens, Monoclonal Antibodies, and Overexpression Cell Lines

Sanyou Biopharmaceuticals (Shanghai) Co., Ltd. announced the launch of a comprehensive product line targeting monkeypox, which includes antigens, monoclona...

September 02, 2024 | News

Guardant Health Japan Secures MHLW Approval for Guardant360® CDx as First Blood-Based Companion Diagnostic for EGFR Exon 20 NSCLC Mutations

Guardant Health Japan , a leading precision oncology company, announced that the Ministry of Health, Labour and Welfare (MHLW) in Japan&nbs...

August 30, 2024 | News

South Korea's Seegene Develops Advanced Multiplex PCR Assays for Mpox and Other Viruses

Develops NovaplexTM MPXV/OPXV Assay and NovaplexTM HSV-1&2/VZV/MPXV Assay - Designed to detect four viruses at once using multip...

August 27, 2024 | News

Mabwell Receives NMPA Approval to Initiate Phase III Study of 9MW2821 in Recurrent or Metastatic Cervical Cancer

Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced that its submission to the Center for Drug Evaluation (C...

August 26, 2024 | News

Stay Connected